Finished Medicines Supply Amoxicillin and Clavulanate Potassium Tablet 625mg

Product Details
Type: Generic Medicines
Material: Plastic
Ethylene Oxide Sterilization: Ethylene Oxide Sterilization
Still deciding? Get samples of $ !
Request Sample
Diamond Member Since 2025

Suppliers with verified business licenses

Type of Ownership
Limited Company
Plant Area
501~1000 square meters
  • Finished Medicines Supply Amoxicillin and Clavulanate Potassium Tablet 625mg
  • Finished Medicines Supply Amoxicillin and Clavulanate Potassium Tablet 625mg
  • Finished Medicines Supply Amoxicillin and Clavulanate Potassium Tablet 625mg
  • Finished Medicines Supply Amoxicillin and Clavulanate Potassium Tablet 625mg
  • Finished Medicines Supply Amoxicillin and Clavulanate Potassium Tablet 625mg
  • Finished Medicines Supply Amoxicillin and Clavulanate Potassium Tablet 625mg
Find Similar Products

Basic Info.

Model NO.
Amc12061-10
Quality Guarantee Period
5 Years
Group
Elderly, Children, Adult
Logo Printing
OEM
Customization
Available
Application
Internal Medicine
Usage Mode
for Oral Administration
Function
Antibiotic
State
Solid
Shape
Tablet
Pharmaceutical Technology
Chemical Synthesis
Standard Available
Bp, Cp
OEM/ODM
Support
Delivery Time
30~60 Days
Transport Package
100′ S/Box, Carton
Specification
875MG+125MG, 7′ S/BOX
Trademark
Shinepharm
Origin
China
HS Code
3004909099
Production Capacity
1000000 Boxes/Month

Product Description


 

Finished Medicines Supply Amoxicillin and Clavulanate Potassium Tablet 625mg


Composition:
Amoxiciln and Clavulanate Potassium 1g Film Coated Tablet: Each film coated tablet contacines Amoxiilin Trihydrate USP equivalent to Amoicilin 875mg and Clavulanate Potassium USP equivalent to Clavalanic acid 125mg.

Indications:
Amoxicilin and Clavulanate Potassium is indicated for treatment of the following bacterial inlections due to susceptible organisms:
-Upper respiratory tract infection (including ENT) , e.g. tonsillitis, sinusitis, otitis media;
-Lower respiratory tract infections, e.g. actue and chronic bronchitis, lobar and bronchopneumonia.
-Gentio-urinary tract infection, e.g. cystitis, urethritis, pyelonephritis, pelvic infection, chancroid, gonorrhoea.
-Skin and soft tissue infection, e.g. boils, abscesses, cellulitis, animal bites, wound infections.
-Bone and joint infections, e.g. osteomyelitis

Dosage and Administration:
Amoxiclin and Clavulanate Potassiummay be administrated without regards to meals. However, to munimize potential pastrointestinal intolerance, administer at the start of a meal.

Adults and Children over 12 years:
Mild-Moderate infections: One Amoxilln and Clavulanate Potassium 375mg tablet every 8 hours.
Severe infections: One Amoxiclin and Clavulanate Potassium 625mg tablet every 8 hours or one 1g tablet every 12 hours.
Severe dental infections( but not generally first-line): one KONN  One Amoiclin and Clavulanate Potassium 375mg tablet every 8hour lor 5 days.

Drug interaction:
Prolongation of bleeding time and prothrombin time have been reported in some patients receving amoxicilin clavulanic acid. Amoxicilin and Clavulanate Potassium should be used with care in patients on anti-coagulant therapy,in common with other broad-spectrum antibiotics, Amoxiciln and Clavulanate Potassium may reduce the efficacy of oral contraceptives and patients should be wamed accordingly.

Storage:
Store at room temperature below 30c, in a dry place, protected from light.

 

Testing terms Standards Results
Identification The retention times of the major peaks     
of the Sample solution correspond to
those of the Standard solution.
Complies
Water ≤11.0% 9.2%
Weight variation Meet the requirement Complies
Dissolution  Rate NLT 85% of the labeled amount of
C16H19N3O5S   and   NLT   80%   of   the   labeled
amount of C8H9NO5.
C16H19N3O5S:
96%  100%  100% 99%  100%  100%
C8H9NO5:
92% 98% 97% 97% 98% 98%
Microbiological
quality
Total aerobe count≤10³cfu/g
The total combined molds and yeasts count≤10²cfu/g
Absence of Escherichia coli
<10cfu/g
<10cfu/g
Negative
Assay Amoxicillin and Clavulanate Potassium              
Tablets contain the equivalent of NLT 90.0%    98.5%
and   NMT    120.0%    of   the    labeled    amount
of amoxicillin(C16H19N3O5S) and clavulanic
acid(C8H9NO5).
C16H19N3O5S:
99.5%
C8H9NO5:
98.5%
 
 



--------------------------------------------------------------------------------------------------

 
 
Finished Medicines Supply Amoxicillin and Clavulanate Potassium Tablet 625mgFinished Medicines Supply Amoxicillin and Clavulanate Potassium Tablet 625mgFinished Medicines Supply Amoxicillin and Clavulanate Potassium Tablet 625mgFinished Medicines Supply Amoxicillin and Clavulanate Potassium Tablet 625mgFinished Medicines Supply Amoxicillin and Clavulanate Potassium Tablet 625mgFinished Medicines Supply Amoxicillin and Clavulanate Potassium Tablet 625mgFinished Medicines Supply Amoxicillin and Clavulanate Potassium Tablet 625mg
 
 
 
 
 
 

 


 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier